Diabetes Dispatch - 2024 Year-End Roundup
Latest Industry Updates
2025 ADA Guidelines: CGM for Type 2, GLP-1s Beyond Weight Loss, and Cannabis Risks
diaTribe shared the new Standards from the American Diabetes Association (ADA), which include first-time recommendations on CGM use in type 2 diabetes, the use of GLP-1 drugs for kidney and heart health, and more. This article will be expanded as diaTribe further reviews the new Standards.
Full Article: diaTribe
Type 2 Diabetes – Not Just for Adults: Children’s Hospital of Michigan Shares Risks & Tips Parents Should Know
The Children’s Hospital of Michigan shares the risks of type 2 diabetes in children and offers tips for parents to increase children’s physical activity and improve eating habits.
Full Article: Little Guide Detroit?
Author: Carrie Budzinski
Hamblen Health Dept., UT Extension offers free Take Charge of Diabetes workshops
The Hamblen County Health Department and the University of Tennessee Extension will offer a free six-week "Take Charge of Your Diabetes Program" workshop this January and February, designed to help people with diabetes and caregivers learn essential self-management skills from healthcare professionals.
Full Article: Citizen Tribune
Do you have an industry update to share? Submit to?[email protected] or post as a comment below
Company Updates
COMEUP 2024
This December, Orange Biomed was featured at the 2024 COMEUP Global Startup Festival as one of 20 startups selected for the exclusive COMEUP STARS program, where we presented our cutting-edge diabetes testing solution, OBM rapid A1c, which addresses the growing need for reliable, fast, and accessible diabetes management tools by using microfluidic technology to enable highly precise, cellular-level analysis for patients.
领英推荐
CES 2025
To kick off 2025, Orange Biomed is bringing OBM rapid A1c to CES 2025 in Las Vegas to demonstrate the device’s unique capabilities that can transform traditional chronic disease management. Learn more about our upcoming exhibition here.?
At CES, as a micro-electro-mechanical application pioneer, Orange Biomed will focus on discovering and connecting with other healthcare innovators to solve major patient challenges.?
“By collaborating with other innovators shaping the future of healthcare, we aim to stay close to patients, shifting from lab-centered to patient-centered care to improve health outcomes.”??- Yeaseul Park, Orange Biomed CEO and Co-Founder?
Attendees are invited to visit Orange Biomed at booth #63432-82 in Eureka Park to experience live demonstrations, engage with our experts, and discuss future innovations.?
Interested in meeting with or interviewing Orange Biomed? Email [email protected] to schedule time with company leadership to learn more about our innovative solution.
Practice News
A small at-home A1C test is coming soon.
Diabetes advocate and Diabetech Podcast host Justin Eastzer previews the OBM rapid A1c and highlights its unique, innovative technology in his recent YouTube video, “A small at-home A1C test is coming soon.” Check out the video to learn more about the device and its benefits.?
Yeaseul Park: Orange Biomed’s New Diabetes Device?
In her recent interview with Scott Douglas Jacobsen of The Good Men Project, Yeaseul Park discusses the development of Orange Biomed’s innovative A1C device, OBM rapid A1c, and highlights challenges with existing technology, sharing insights on clinical trials, FDA clearance, and its potential global impact.?